NYSE · IBER
Ibere Pharmaceuticals
Financial Services · Shell Companies
$10.18
Down-$0.03 (-0.29%)
Updated Aug 31, 2026, 8:24 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 175.61M
- P/E ratio
- 74.91
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 44.5K
- Avg. volume
- 85.05K
Price performance
IBER price history
1M range · 0 trading sessions · Daily adjusted prices
IBER does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest IBER news
The latest Smart Investors Daily articles mentioning IBER.
Stock researchCompany · Overview
IBER research
Overview
Company profile and research snapshot.
Company profile
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
